(Q43433302)

23 November 2017

title

Paradoxical worsening of psoriasis when switching from etanercept to adalimumab: a case series (English)

1 reference

23 November 2017

0 references

Tina Bhutani

1

1 reference

23 November 2017

John Koo

series ordinal

2

1 reference

23 November 2017

publication date

5 June 2010

1 reference

Journal of Dermatological Treatment

23 November 2017

published in

1 reference

23 November 2017

volume

22

1 reference

23 November 2017

issue

2

1 reference

23 November 2017

page(s)

75-78

1 reference

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09546630903559814

A randomized trial of etanercept as monotherapy for psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546630903559814

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546630903559814

Economic evaluation of systemic therapies for moderate to severe psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546630903559814

10.3109/09546630903559814

21 January 2018

Identifiers

DOI

1 reference

23 November 2017

1 reference